{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T15:53:23Z","timestamp":1748361203508,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12882-019-1310-5","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T13:03:02Z","timestamp":1554296582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Small intestinal perforation due to a huge gastrointestinal stromal tumor in a kidney transplant recipient: a case report and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Ryohei","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5358-0980","authenticated-orcid":false,"given":"Kazunobu","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotaro","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Jinzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"1310_CR1","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/ndt\/gfl807","volume":"22","author":"A Agaimy","year":"2007","unstructured":"Agaimy A, Wunsch PH. Gastrointestinal stromal tumours (GIST) in kidney transplant recipients--a report of two cases. Nephrol Dial Transplant. 2007;22:1489\u201390.","journal-title":"Nephrol Dial Transplant"},{"key":"1310_CR2","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/TP.0b013e31816c7e2f","volume":"85","author":"RF Saidi","year":"2008","unstructured":"Saidi RF, Sepehr A, Cosimi AB, Hertl M. Gastrointestinal stromal tumor in a liver transplant recipient. Transplantation. 2008;85:1363.","journal-title":"Transplantation."},{"key":"1310_CR3","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1016\/j.transproceed.2008.04.017","volume":"40","author":"MA Camargo","year":"2008","unstructured":"Camargo MA, Boin I, Mainnardi JP, de Lourdes M, Ayrizono S, Coy CS, et al. Extragastrointestinal stromal tumor and liver transplantation: case report and review. Transplant Proc. 2008;40:3781\u20133.","journal-title":"Transplant Proc"},{"key":"1310_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10157-011-0550-x","volume":"16","author":"H Tu","year":"2012","unstructured":"Tu H, Li Q, Cai J, Chen Z, Yang H, Jiang H, et al. Extragastrointestinal stromal tumor in a kidney transplant recipient. Clin Exp Nephrol. 2012;16:350\u20133.","journal-title":"Clin Exp Nephrol"},{"key":"1310_CR5","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1007\/s10637-011-9769-3","volume":"30","author":"KE Mulder","year":"2012","unstructured":"Mulder KE, Egorin MJ, Sawyer MB. Renal dysfunction in a renal transplant patient treated concurrently with cyclosporine and imatinib. Investig New Drugs. 2012;30:2400\u20132.","journal-title":"Investig New Drugs"},{"key":"1310_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000348817","volume":"6","author":"A Mrzljak","year":"2013","unstructured":"Mrzljak A, Kosuta I, Skrtic A, Kardum-Skelin I, Vrhovac R. Metachronous gastrointestinal stromal tumor and acute leukemia after liver transplantation for cholangiocellular carcinoma: is there a link? Case Rep Oncol. 2013;6:163\u20138.","journal-title":"Case Rep Oncol"},{"key":"1310_CR7","doi-asserted-by":"publisher","unstructured":"Cimen S, Guler S, Panek R, Alwayn I. Gastrointestinal stromal tumour in a recipient with kidney transplantation. BMJ Case Rep. 2015;2015. \n                    https:\/\/doi.org\/10.1136\/bcr-2014-207178\n                    \n                  .","DOI":"10.1136\/bcr-2014-207178"},{"key":"1310_CR8","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/ajco.12506","volume":"13","author":"CY Cheung","year":"2017","unstructured":"Cheung CY, Lo SH, Chan CK, Li FK, Cheng IK, Chau KF. Gastrointestinal stromal tumors in kidney transplant recipients: report of two cases and literature review. Asia Pac J Clin Oncol. 2017;13:104\u20136.","journal-title":"Asia Pac J Clin Oncol"},{"key":"1310_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577\u201380.","journal-title":"Science."},{"key":"1310_CR10","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/modpathol.3880210","volume":"13","author":"M Miettinen","year":"2000","unstructured":"Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000;13:1134\u201342.","journal-title":"Mod Pathol"},{"key":"1310_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0002-9440(10)63279-8","volume":"165","author":"RB West","year":"2004","unstructured":"West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165:107\u201313.","journal-title":"Am J Pathol"},{"key":"1310_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/hupa.2002.123545","volume":"33","author":"CD Fletcher","year":"2002","unstructured":"Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459\u201365.","journal-title":"Hum Pathol"},{"key":"1310_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1470-2045(11)70299-6","volume":"13","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Vehtari A, Riihimaki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13:265\u201374.","journal-title":"Lancet Oncol"},{"key":"1310_CR14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jama.2012.347","volume":"307","author":"H Joensuu","year":"2012","unstructured":"Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schutte J, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307:1265\u201372.","journal-title":"JAMA."},{"key":"1310_CR15","first-page":"699","volume":"2","author":"A Frolov","year":"2003","unstructured":"Frolov A, Chahwan S, Ochs M, Arnoletti JP, Pan ZZ, Favorova O, et al. Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. Mol Cancer Ther. 2003;2:699\u2013709.","journal-title":"Mol Cancer Ther"},{"key":"1310_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00003088-200544090-00001","volume":"44","author":"B Peng","year":"2005","unstructured":"Peng B, Lloyd P, Schran H. Clinical pharmacokinetics of imatinib. Clin Pharmacokinet. 2005;44:879\u201394.","journal-title":"Clin Pharmacokinet"},{"key":"1310_CR17","doi-asserted-by":"publisher","first-page":"10391","DOI":"10.1073\/pnas.96.18.10391","volume":"96","author":"R Khanna","year":"1999","unstructured":"Khanna R, Bell S, Sherritt M, Galbraith A, Burrows SR, Rafter L, et al. Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc Natl Acad Sci U S A. 1999;96:10391\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1310_CR18","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-13-0371","volume":"73","author":"S Rusakiewicz","year":"2013","unstructured":"Rusakiewicz S, Semeraro M, Sarabi M, Desbois M, Locher C, Mendez R, et al. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors. Cancer Res. 2013;73:3499\u2013510.","journal-title":"Cancer Res"},{"key":"1310_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10555-007-9077-8","volume":"26","author":"H Seeliger","year":"2007","unstructured":"Seeliger H, Guba M, Kleespies A, Jauch KW, Bruns CJ. Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis. Cancer Metastasis Rev. 2007;26:611\u201321.","journal-title":"Cancer Metastasis Rev"},{"key":"1310_CR20","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1093\/annonc\/mdq076","volume":"21","author":"P Schoffski","year":"2010","unstructured":"Schoffski P, Reichardt P, Blay JY, Dumez H, Morgan JA, Ray-Coquard I, et al. A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors. Ann Oncol. 2010;21:1990\u20138.","journal-title":"Ann Oncol"},{"key":"1310_CR21","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1158\/1078-0432.CCR-12-0490","volume":"18","author":"K Eechoute","year":"2012","unstructured":"Eechoute K, Fransson MN, Reyners AK, de Jong FA, Sparreboom A, van der Graaf WT, et al. A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients. Clin Cancer Res. 2012;18:5780\u20137.","journal-title":"Clin Cancer Res"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1310-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-019-1310-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-019-1310-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T23:11:58Z","timestamp":1585782718000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-019-1310-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1310"],"URL":"https:\/\/doi.org\/10.1186\/s12882-019-1310-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"120"}}